@mennovanhoven Heb jij ook de overname van ITT gezien? Dat is best een flinke kluif (4,7 miljard overname op een beurswaarde van 14 miljard voor ITT zelf). O.b.v. de cijfers SPXFlow ziet de overname er wel goed uit.
@dividendhike Isn't that strange.... Guidance is approx 35% lower compared to expectations. The stock price drops "only" 20%. (I agree 20% on itself is a lot, but putting it in context). Unfortunately the tariffs are crazy and will hit these type of companies hard.
@DividendWave Is great to see that the cloud revenue is still growing y-o-y with 30%+. As long as the revenue and profitability of the cloud division is growing fast the investment seems to be worth it :)
@Schuldensuehner The decrease in FED Balance Sheet is even more interesting. Less dollars from the Central Bank in Bonds will definitely have an impact on effective interest rates on bonds
@DividendWave Agreed. Maybe I am too conservative. I keep them in my portfolio, mainly due to the great historic performance and their dominant positief (together with home depot)
@European_DGI Parker Hannifin
Texas Instruments
Kering
Unilever
Alphabet
Alphabet does not pay a dividend, however their share buybacks are so massive that I consider it as a dividend. Since buying back 2-3% of the share per year give a huge advantage for the current shareholders
@DividendWave What's your opinion? I think they should stop temporarily share buybacks and reduce debt. The net debt is too high anticipating on lower sales and operating profit
@European_DGI Isn't it insane that most big acquisitions fail. Companies with organic growth (due to impressive R&D) is so much better compared to companies acquire (multiple) companies per decade.
@thedude_alive@mennovanhoven@BelBelnl Het is teleurstellend dat Medtronic geen omzetgroei laat zien. De afgelopen 5 jaar schommelt de omzet rond de 32 miljard dollar. Dat is op lange termijn niet positief. Ik heb ze zelf overigens ook nog (wel een deel verkocht)